DPRK-linked actors use GitHub C2 and LNK phishing in South Korea, enabling persistent PowerShell control and data ...
GSD-2 is a structured project execution engine that takes a vague spec and delivers a working implementation through a research → plan → execute → verify pipeline. It currently ships with a TUI as the ...
Pfizer said a mid-stage study of its investigational CDK4 inhibitor atirmociclib met its key goal in certain patients with breast cancer. Pfizer on Tuesday said the randomized Phase 2 study met its ...
Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...
WHAT THEY ARE DOING TO COMBAT THE CONSTRUCTION. WITH THE PENN AVENUE PHASE TWO STREETSCAPE PROJECT IS COMPLETE. THIS AREA HERE WILL HAVE NEW SIDEWALKS, TRAFFIC LIGHTS AND A LOT MORE. HOWEVER, BUSINESS ...
Pfizer (PFE) said its Phase 2 study of tilrekimig (PF-07275315), a trispecific antibody for atopic dermatitis, showed positive results. The study met its primary endpoint, with tilrekimig showing a ...
Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment of first-time recurrent ...
A Metropolitan Transportation Authority rendering shows a conceptual interior of a future Second Avenue Subway station in Harlem, illustrating platform circulation, train clearances and passenger flow ...
President Donald Trump’s administration formally launched the second phase of its plan to end the war between Israel and Hamas this week, shifting from a ceasefire framework toward a post-ceasefire ...
Michael Block is a 14 time GLAM Award nominated writer, producer, and host of the podcast Block Talk. Throughout his time in the entertainment industry, he has worked on and off Broadway as a stage ...
More antibodies take aim at seeded propagation. New data ties tangle location to deficits in specific cognitive domains. Three first-in-human studies for antibodies targeting different parts of tau ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results